ZEPBOUND Trademark

Trademark Overview

On Tuesday, August 2, 2022, a trademark application was filed for ZEPBOUND with the United States Patent and Trademark Office. The USPTO has given the ZEPBOUND trademark a serial number of 97530451. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, November 19, 2024. This trademark is owned by Eli Lilly and Company. The ZEPBOUND trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of obesity

General Information

Serial Number97530451
Word MarkZEPBOUND
Filing DateTuesday, August 2, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, November 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements

Description of MarkThe mark consists of the wording "ZEPBOUND" in stylized font, "ZEP" in blue and "BOUND" in green with a cutout of an arrowhead on the left side of the letter "B" and three green arrowheads after the word.
Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of obesity
Indication of Colors claimedThe color(s) blue and green is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Friday, August 5, 2022NEW APPLICATION ENTERED
Tuesday, August 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 24, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, February 1, 2023ASSIGNED TO EXAMINER
Wednesday, February 1, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 1, 2023NON-FINAL ACTION E-MAILED
Wednesday, February 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 15, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 15, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, February 15, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 15, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, February 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 17, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 17, 2023SOU EXTENSION 1 FILED
Tuesday, October 17, 2023SOU EXTENSION 1 GRANTED
Thursday, October 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 28, 2024SOU EXTENSION 2 GRANTED
Thursday, March 28, 2024SOU TEAS EXTENSION RECEIVED
Thursday, March 28, 2024SOU EXTENSION 2 FILED
Friday, March 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 4, 2024SOU EXTENSION 3 FILED
Friday, October 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, November 20, 2024SOU EXTENSION 3 GRANTED
Wednesday, November 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 20, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

zepbound pharmaceutical preparations obesity namely treatment